17Feb 2023
Multiomics STEP up in correlative analysis of response to CAR T cells

Multiomics STEP up in correlative analysis of response to CAR T cells

Plasma cell-free DNA analysis has emerged as a powerful liquid biopsy assay to assess circulating tumor DNA in response to cancer treatments. A new study shows that cell-free DNA can also inform expansion kinetics and tumor-infiltration patterns in patients receiving chimeric antigen receptor T cells. Together with circulating tumor DNA, it provides vivid prognostic insights into intratumoral dynamics.

  • #oncology

Like

Save

Share